| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2000-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21dc61ab6f7f8c2c4ba09a67deb61acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95e35072f0e5daf87ecb179883dafb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54bd477c2128d201c62e7b8fa04921f |
| publicationDate |
2000-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-20004931-L |
| titleOfInvention |
Use of dexmedetomidine for sedation in intensive care units |
| abstract |
The present invention relates to a method of sedating a patient while he is in an intensive care unit (ICU). The method comprises administering dexmedetomidine or a pharmaceutically acceptable salt thereof to a patient in need thereof for a sufficient period of time. Furthermore, the present invention relates to a method of sedating a patient in the intensive care unit by administering dexmedetomidine or a pharmaceutically acceptable salt thereof, wherein dexmedetomidine is essentially the one active agent or agent. |
| priorityDate |
1998-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |